259 related articles for article (PubMed ID: 19268184)
1. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
Benoit M; Pon J; Zimmermann MA
Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
[No Abstract] [Full Text] [Related]
2. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].
Chéreau I; Gorwood P; Mouchabac S
Encephale; 2009 Jan; Suppl 3():S97-100. PubMed ID: 19268186
[No Abstract] [Full Text] [Related]
3. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
Canceil O; Limosin F; Passerieux C
Encephale; 2009 Jan; Suppl 3():S101-7. PubMed ID: 19268178
[No Abstract] [Full Text] [Related]
4. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
Buis C; Gourion D; Vaiva G
Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
[No Abstract] [Full Text] [Related]
5. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
Dassa D; Lacambre M; Vacheron MN
Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
[No Abstract] [Full Text] [Related]
6. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of Canadian psychiatry].
Stip E
Encephale; 2009 Jan; Suppl 3():S115-8. PubMed ID: 19268180
[No Abstract] [Full Text] [Related]
7. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
Costentin J
Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
[No Abstract] [Full Text] [Related]
8. [Expert opinion on APAP (Prolonged action atypical antipsychotic agents). Conclusion].
Guelfi JD
Encephale; 2009 Jan; Suppl 3():S123-4. PubMed ID: 19268182
[No Abstract] [Full Text] [Related]
9. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Foreword].
Guelfi JD; Costentin J; Terra JL
Encephale; 2009 Jan; Suppl 3():S85-6. PubMed ID: 19268183
[No Abstract] [Full Text] [Related]
10. The attitude of patients towards antipsychotic depot treatment.
Heres S; Schmitz FS; Leucht S; Pajonk FG
Int Clin Psychopharmacol; 2007 Sep; 22(5):275-82. PubMed ID: 17690596
[TBL] [Abstract][Full Text] [Related]
11. [Longterm therapy of schizophrenia].
Pajonk FG; Wobrock T; Falkai P
Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
[No Abstract] [Full Text] [Related]
12. [CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
Steinert T
Psychiatr Prax; 2007 Jul; 34(5):255-7. PubMed ID: 17607643
[No Abstract] [Full Text] [Related]
13. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
Naber D; Lambert M; Karow A
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
[TBL] [Abstract][Full Text] [Related]
14. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Müller P
Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
[No Abstract] [Full Text] [Related]
15. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
Chue P
J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
[TBL] [Abstract][Full Text] [Related]
16. [Quotidien prescription: between references and reality].
Verdoux H
Encephale; 2006 Jan; 32 Pt 2():S10-1. PubMed ID: 16800079
[No Abstract] [Full Text] [Related]
17. [Compliance problems in treatment of schizophrenic patients].
Barnas C; Hummer M; Fleischhacker WW
Wien Med Wochenschr; 1998; 148(11-12):281-3. PubMed ID: 9746971
[TBL] [Abstract][Full Text] [Related]
18. Algorithm for treatment-refractory schizophrenia.
Koshino Y
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S9-13. PubMed ID: 10560891
[TBL] [Abstract][Full Text] [Related]
19. Overview of partial compliance.
Marder SR
J Clin Psychiatry; 2003; 64 Suppl 16():3-9. PubMed ID: 14680412
[TBL] [Abstract][Full Text] [Related]
20. Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.
Citrome L
CNS Spectr; 2012 Nov; 17 Suppl 1():1-9. PubMed ID: 23448847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
